(Q39310787)

English

Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

toll-like receptor

0 references

Salmonella typhi

object named as

Salmonella typhi

1 reference

based on heuristic

inferred from title

8

object named as

Shibo Jiang

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

7

object named as

Lanying Du

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

10

object named as

Yusen Zhou

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

9

object named as

Zhihua Kou

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

author name string

Jing Wen

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Yi Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Guangyu Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Shuang Tong

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Hong Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Xia Jin

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

0 references

publication date

20 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

5733-5739

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Moving ahead an HIV vaccine: use both arms to beat HIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

The immune response during acute HIV-1 infection: clues for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Targeting early infection to prevent HIV-1 mucosal transmission.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Enhancement by ampicillin of antibody responses induced by a protein antigen and a DNA vaccine carried by live-attenuated Salmonella enterica serovar Typhi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Improved NYVAC-based vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Bacterial ghosts (BGs)--advanced antigen and drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Bacterial ghosts are an efficient delivery system for DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Overlapping genes in bacteriophage phiX174

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Pattern recognition receptors and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

A method to generate recombinant Salmonella typhi Ty21a strains expressing multiple heterologous genes using an improved recombineering strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.008

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.07.008

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39310787&oldid=1819526026"